Founded in January 2018, the firm is a venture capital based in Shenzhen, China. The firm focused on big data and IOT-related healthcare investment opportunities. The firm is currently managing a 500 million RMB fund and is actively looking to invest 10-20 new deals in the following 12 months. The firm invests mostly in Medical Devices, Diagnostics, and Digital Health companies but will also consider drugs in applicable cases. The firm is currently looking for new opportunities globally, however, following China’s latest healthcare development strategy would be an important consideration although not required for their investment opportunities. The size of investment can vary from 10 – 30 million depending on the deal.
The firm is interested in medtech, diagnostics, and digital health companies that are seeking for early financing round. The firm’s sweet spot is to invest in angel to pre-A round. The firm will not invest in B round or later rounds. The firm is especially interested in technology with a big-data component and has invested in molecular diagnostics and digital health companies previously. The firm is opportunistic in terms of subsectors and indications.
The firm is seeking to invest in management teams with strong research or industry background. Management teams that graduated from the world’s top universities or has worked for big pharma is a plus. The firm also prefers serial entrepreneurs with successful track records.
If you are interested in more information about this investor and other investors tracked by LSN, please email 4dmeetsai@lifesciencenation.com.
Next Phase Newsletter 
Leave a Reply